Portal de investigación
ESTUDIO EPIDEMIOLOGICO DE VALIDACION DEL CUESTIONARIO DE CALIDAD DE VIDA EN PACIENTES CON CANCER DE PROSTATA
Datos básicos
- Protocolo:
- CAP1-06/CAP107
- EUDRACT:
- NO PROCEDE
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Astellas Pharma, S.A.
Resultados del Ensayo Clínico
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs
Article. 10.3390/ijms22157913. 2021
Nuclear-medicine probes: Where we are and where we are going
Gonzalez-Montoro A; (...); Javier Gonzalez, Antonio
Article. 10.1002/mp.15690. 2022
Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines.
Rivero-Buceta, Eva; (...); Botella, Pablo
Article. 10.1016/j.ijpharm.2024.124623. 2024
Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.
Garcia-Dominguez, Ximo; (...); Marco-Jimenez, Francisco
Article. 10.3390/jcm11113068. 2022
The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?
Perez-Ardavin J; (...); Vera-Donoso CD
Article. 10.23736/S1824-4785.22.03416-1. 2022
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Oto, Julia; (...); Medina, Pilar
Article. 10.1016/j.jprot.2024.105357. 2025